Home Applications 215902 Application 215902
Type ANDA
Sponsor AUROBINDO PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SAFINAMIDE MESYLATE SAFINAMIDE MESYLATE TABLET;ORAL EQ 50MG BASE No No 002 SAFINAMIDE MESYLATE SAFINAMIDE MESYLATE TABLET;ORAL EQ 100MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215902-001 SAFINAMIDE MESYLATE SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 A215902-002 SAFINAMIDE MESYLATE SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 50 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 c2088c7a36db…2026-09-14 22:38:34 2026-08 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A215902-001 SAFINAMIDE MESYLATE EQ 50MG BASE TABLET / ORAL 2023-06-14 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 A215902-002 SAFINAMIDE MESYLATE EQ 100MG BASE TABLET / ORAL 2023-06-14 1c564ffb4f44…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Xadago SAFINAMIDE MESYLATE MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. c4d65f28-983f-42b4-bb23-023ae0fe81b2 2026-10-05 Warnings, Adverse reactions Name fallback generic name: SAFINAMIDE MESYLATE
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 74741 ORIG 2023-07-13